Logo

Prescription Iron Supplements

Niferex

Give your body the iron it needs.
Get the most from Niferex.

Two iron forms provides enhanced tolerability plus optimal absorption

  • 50 mg of Sumalate® (ferrous asparto glycinate) – chelated ferrous iron complex with 40% absorption1-5
    – High bioavailability of Sumalate is the engine of the formulation to deliver maximal iron uptake possible from supplemental iron2-7
    – About 3x more bioavailability than ferrous sulfate3-5
  • 100 mg of polysacchride iron complex – highly tolerable iron form
    Bioavailable ferric iron complex with a demonstrated safety and tolerance profile,
    making it an ideal candidate for a high payload iron supplement8

Two iron forms offer complimentary absorption to ensure maximal daily iron intake possible from an iron supplement.8

Visit Website

*Most eligible patients will pay no more than $20 for each NiferexTM fill. After the first $20 out of pocket, NiferexTM covers the remaining co-pay up to $60. This offer is good for 12 fills. Patient will be responsible for any additional money due.
THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE.
Quatrefolic® is a registered trademark of Gnosis, SpA, covered by one or more claims of U.S. Patent # 7,947,662 CAS# 1181972-37-1
Sumalate® is a registered trademark of Albion Laboratories, Inc., covered by one or more claims of U.S. Patent Nos. 6,716,814, 8,007,846, and 8,425,956.
Marketed by Avion Pharmaceuticals LLC, Alpharetta, GA 30022
REFERENCES
1. Niferex™ Prescribing Information, Avion Pharmaceuticals, LLC, 2016. 2. Kamdi SP, Palkar PJ. Efficacy and safety of ferrous asparto glycinate in the management of iron deficiency anaemia in pregnant women. J Obstet Gynaecol. 2014; Early Online: 1–5. doi:10.3109/01443615.2014.930098. Accessed December 29, 2014. 3. Data on File. Avion Pharmaceuticals LLC, Alpharetta, GA. 4. Bovell-Benjamin AC, Viteri FE, and Allen LH. Iron absorption from ferrous bisglycinate and ferric trisglycinate in whole maize is regulated by iron status. Am J Clin Nutr. 2000; 71:1563–1569. 5. Pineda O, Ashmead HD, Perez JM, Lemus CP. Effectiveness of iron amino acid chelate on the treatment of iron deficiency anemia in adolescents. J App Nutr. 1994; 46(1,2):2-13. 6. Duque X, Martinez H, Vilchis-Gil J, et al. Effect of supplementation with ferrous sulfate or iron bis-glycinate chelate on ferritin concentration in Mexican schoolchildren: A randomized controlled trial. Nutr J. 2014; 13(71):1-10.doi:10.1186/1475-2891-13-71. Accessed January 5, 2014. 7. Szarfarc SC, Núñez de Cassana LM, Fujimori E, Guerra-Shinohara EM, de ‘Oliveira IMEV. Relative effectiveness of iron bis-glycinate chelate (Ferrochel) and ferrous sulfate in the control of iron deficiency in pregnant women. Arch Latin Nutr. 2001; http://www.scielo.org.ve/scielo.php?script=sci_arttext&pid=S0004-06222001000500009&lng= en&nrm=iso. 8. Zariwala MG, Somavarapu S, Farnaud S, Renshaw D. Comparison study of oral iron preparations using a human intestinalmodel. Sci Pharm. 2013; 81:1123–1139
IMPORTANT SAFETY INFORMATION

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

WARNING: Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.

Niferex™ is a multivitamin/multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency.

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

Niferex™ is contraindicated in patients with a known hypersensitivity to any of the ingredients. Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. Folic acid in doses above 1.0mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.

Store at 20° – 25°C (68° – 77°F); excursions permitted to 15° – 30°C (59° – 86°F) [See USP Controlled Room Temperature.]

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.